MeVis Medical Solutions AG (FRA:M3V)
Germany flag Germany · Delayed Price · Currency is EUR
25.60
0.00 (0.00%)
At close: Jan 27, 2026

FRA:M3V Income Statement

Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
16.6416.9717.3418.7616.2117.13
Revenue Growth (YoY)
-5.71%-2.14%-7.57%15.71%-5.35%-5.21%
Cost of Revenue
10.7110.5410.3410.179.299.18
Gross Profit
5.936.4378.596.927.95
Selling, General & Admin
0.580.570.560.560.470.44
Other Operating Expenses
1.831.751.481.481.311.78
Operating Expenses
2.562.452.142.131.912.39
Operating Income
3.373.984.866.475.025.56
Interest Expense
---0---0
Interest & Investment Income
0.120.150.11-0.160.3
Earnings From Equity Investments
---0.18--
Currency Exchange Gain (Loss)
-0.13-0.5-1.011.230.06-0.37
Other Non Operating Income (Expenses)
1.051.051.07---
EBT Excluding Unusual Items
4.424.695.037.885.245.49
Legal Settlements
-----0.610.3
Pretax Income
4.424.695.037.884.635.79
Income Tax Expense
0.120.130.110.090.090.09
Net Income
4.34.564.927.794.555.7
Net Income to Common
4.34.564.927.794.555.7
Net Income Growth
-25.19%-7.29%-36.84%71.35%-20.31%-29.33%
Shares Outstanding (Basic)
222222
Shares Outstanding (Diluted)
222222
EPS (Basic)
2.362.512.704.282.503.13
EPS (Diluted)
2.362.512.704.282.503.13
EPS Growth
-25.19%-7.29%-36.84%71.35%-20.31%-29.33%
Free Cash Flow
-2.845.774.729.082.79
Free Cash Flow Per Share
-1.563.172.604.991.53
Dividend Per Share
1.1301.1300.950---
Dividend Growth
18.95%18.95%----
Gross Margin
35.62%37.91%40.38%45.80%42.70%46.42%
Operating Margin
20.25%23.46%28.05%34.46%30.94%32.47%
Profit Margin
25.87%26.87%28.37%41.52%28.04%33.30%
Free Cash Flow Margin
-16.76%33.30%25.18%56.00%16.27%
EBITDA
3.524.114.966.565.145.73
EBITDA Margin
21.16%24.25%28.60%34.96%31.71%33.45%
D&A For EBITDA
0.150.130.10.090.130.17
EBIT
3.373.984.866.475.025.56
EBIT Margin
20.25%23.46%28.05%34.46%30.94%32.47%
Effective Tax Rate
2.65%2.70%2.27%1.11%1.84%1.56%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.